Skip to main content
Top
Published in: European Journal of Epidemiology 10/2011

Open Access 01-10-2011 | COMMENTARY

STROBE-ME too!

Author: Cornelia M. van Duijn

Published in: European Journal of Epidemiology | Issue 10/2011

Login to get access

Excerpt

The past decade has seen a growing catalogue of guidelines for reporting findings of epidemiologic studies [14]. The basic rationale of each of these guidelines is that these efforts will ultimately improve the credibility of epidemiological research and publications. Recently, the European Journal of Epidemiology published the guide lines for prognostic studies in genomics [5, 6]. In this issue the journal includes the paper of the Gallo et al. entitled ‘STrengthening the Reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME). In 2004, the STROBE initiative provided a checklist of 22 items to be reported in epidemiological studies. The present STROBE-ME initiative builds on the STROBE Statement [2]. It is difficult to suppress a ‘me-too’ feeling and the question raised by Vandenbroucke comes to mind: for whom do these guidelines toll [4]? Why do we need this extension of the STROBE statement given the abundance guidance? …
Literature
1.
go back to reference Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010;40:35–53.PubMedCrossRef Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010;40:35–53.PubMedCrossRef
2.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296.CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296.CrossRef
3.
go back to reference Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, et al. STrengthening the REporting of genetic association studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009;6:e22.PubMedCrossRef Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, et al. STrengthening the REporting of genetic association studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009;6:e22.PubMedCrossRef
4.
go back to reference Vandenbroucke JP. STREGA, STARD, STROBE, MOOSE, SQUIRE, GNOSIS, PRISMA, ORION, TREND, QUOROM, COREQ, REMA, RK and CONSORT: for whom does the guideline toll? J Clin Epidemiol. 2009;62:594–6.PubMedCrossRef Vandenbroucke JP. STREGA, STARD, STROBE, MOOSE, SQUIRE, GNOSIS, PRISMA, ORION, TREND, QUOROM, COREQ, REMA, RK and CONSORT: for whom does the guideline toll? J Clin Epidemiol. 2009;62:594–6.PubMedCrossRef
5.
go back to reference Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Epidemiol. 2011;26:255–9. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Epidemiol. 2011;26:255–9.
6.
go back to reference Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, et al. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol. 2011;26:313–37. Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, et al. Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol. 2011;26:313–37.
7.
go back to reference Editorial. Researcher, two universities sued over validity of prostate cancer test. Science. 2009;325:1484. Editorial. Researcher, two universities sued over validity of prostate cancer test. Science. 2009;325:1484.
8.
go back to reference Empana JP, Bean K, Guibout C, Thomas F, Bingham A, et al, On behalf of the PPS3 Study Group. Paris prospective study III: a study of novel heart rate parameters, baroreflex sensitivity and risk of sudden death. Eur J Epidemiol. 2011. doi:10.1007/s10654-011-9618-x. Empana JP, Bean K, Guibout C, Thomas F, Bingham A, et al, On behalf of the PPS3 Study Group. Paris prospective study III: a study of novel heart rate parameters, baroreflex sensitivity and risk of sudden death. Eur J Epidemiol. 2011. doi:10.​1007/​s10654-011-9618-x.
9.
go back to reference Gimeno D, Delclos GL, Ferrie JE, De Vogli R, Elovainio M, et al. Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study. Eur J Epidemiol. 2011;26:135–44. Gimeno D, Delclos GL, Ferrie JE, De Vogli R, Elovainio M, et al. Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study. Eur J Epidemiol. 2011;26:135–44.
10.
go back to reference Montonen J, Drogan D, Joost HG, Boeing H, Fritsche A, et al. Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes. Eur J Epidemiol. 2011;26:29–38. Montonen J, Drogan D, Joost HG, Boeing H, Fritsche A, et al. Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes. Eur J Epidemiol. 2011;26:29–38.
11.
go back to reference Faramawi MF, Caffrey JL, Amanzadeh J, Sharpa LD, Qualls-Hampton R. Cystatin C estimated renal dysfunction predicts T wave axis deviation in US adults: results from NHANES III. Eur J Epidemiol. 2011;26:101–7. Faramawi MF, Caffrey JL, Amanzadeh J, Sharpa LD, Qualls-Hampton R. Cystatin C estimated renal dysfunction predicts T wave axis deviation in US adults: results from NHANES III. Eur J Epidemiol. 2011;26:101–7.
12.
go back to reference Østergaard SD, Dinesen PT, Foldager L. Quantifying the value of markers in screening programmes. Eur J Epidemiol. 2010;25:151–4. Østergaard SD, Dinesen PT, Foldager L. Quantifying the value of markers in screening programmes. Eur J Epidemiol. 2010;25:151–4.
13.
go back to reference Sabanayagam C, Shankar A, Li J, Pollard C, Ducatman A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur J Epidemiol. 2009;24:369–73. Sabanayagam C, Shankar A, Li J, Pollard C, Ducatman A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur J Epidemiol. 2009;24:369–73.
Metadata
Title
STROBE-ME too!
Author
Cornelia M. van Duijn
Publication date
01-10-2011
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 10/2011
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-011-9628-8

Other articles of this Issue 10/2011

European Journal of Epidemiology 10/2011 Go to the issue